Literature DB >> 18690484

Mapping the prescriptiome to fractures in men--a national analysis of prescription history and fracture risk.

B Abrahamsen1, K Brixen.   

Abstract

SUMMARY: A nationwide case-control study was performed in 62,865 men aged 50+ using fracture data from the national hospital discharge register to screen all redeemed prescriptions in the past 5 years for significant mapping to fracture risk, employing measures to control for false discovery rate.
INTRODUCTION: Osteoporosis in men is frequently related to alcohol abuse, hypogonadism, hypercalciuria, or the use of glucocorticoids. Very limited information is available on the impact of other medications on fracture risk in men.
METHODS: We conducted a nationwide population-based case-control study collecting fracture data from the Danish National Hospital Discharge Register and prescriptions from the National Prescriptions Database (1995-2000). We included men aged 50+ years, with hospital-treated fractures in the year 2000 (n = 15,716), and age- and sex-matched controls (n = 47,149).
RESULTS: We identified 3.2 million redemptions of prescriptions for 1,073 different drugs. The analysis confirmed associations between fracture risk and use of sedatives, anti-epileptics, anti-psychotics, anxiolytics, SSRI, opioids and other analgesics, loop diuretics, and glucorticoids. New associations were also found. We observed an odds ratio (OR [95% CI] for any fracture) for fracture in users of dopaminergic agents (1.6 [1.3-1.9]) and iron compounds (1.2 [1.1-1.5]). The largest impact on fracture risk at population level was exerted by loop diuretics and analgesics.
CONCLUSIONS: An array of drugs is associated with fracture risk in men. The "prescriptiome" analysis can be used as a surveillance tool for drug-induced osteoporosis and in the planning of preventive measures.

Entities:  

Mesh:

Year:  2008        PMID: 18690484     DOI: 10.1007/s00198-008-0711-2

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  69 in total

1.  Exposure to tricyclic and selective serotonin reuptake inhibitor antidepressants and the risk of hip fracture.

Authors:  Richard Hubbard; Paddy Farrington; Chris Smith; Liam Smeeth; Anne Tattersfield
Journal:  Am J Epidemiol       Date:  2003-07-01       Impact factor: 4.897

2.  Corticosteroid use and risk of hip fracture: a population-based case-control study in Denmark.

Authors:  P Vestergaard; M L Olsen; S Paaske Johnsen; L Rejnmark; H Toft Sørensen; L Mosekilde
Journal:  J Intern Med       Date:  2003-11       Impact factor: 8.989

3.  Opioid analgesics and the risk of hip fracture in the elderly: codeine and propoxyphene.

Authors:  R I Shorr; M R Griffin; J R Daugherty; W A Ray
Journal:  J Gerontol       Date:  1992-07

4.  Fracture risk in users of oral anticoagulants: a nationwide case-control study.

Authors:  Lars Rejnmark; Peter Vestergaard; Leif Mosekilde
Journal:  Int J Cardiol       Date:  2006-10-18       Impact factor: 4.164

5.  Fracture risk associated with the use of morphine and opiates.

Authors:  P Vestergaard; L Rejnmark; L Mosekilde
Journal:  J Intern Med       Date:  2006-07       Impact factor: 8.989

6.  Prevalence of osteoporosis during long-term androgen deprivation therapy in patients with prostate cancer.

Authors:  Juan Morote; Jacques Planas Morin; Anna Orsola; Jose M Abascal; Carles Salvador; Enrique Trilla; Carles X Raventos; Lluis Cecchini; Gloria Encabo; Jaume Reventos
Journal:  Urology       Date:  2007-03       Impact factor: 2.649

7.  Beta-blocker use and risk of fractures in men and women from the general population: the MONICA/KORA Augsburg cohort study.

Authors:  C Meisinger; M Heier; O Lang; A Döring
Journal:  Osteoporos Int       Date:  2007-03-01       Impact factor: 4.507

8.  Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial.

Authors:  Yoshihiro Sato; Yoshiaki Honda; Jun Iwamoto; Tomohiro Kanoko; Kei Satoh
Journal:  JAMA       Date:  2005-03-02       Impact factor: 56.272

Review 9.  Inhaled corticosteroids effects on bone in asthmatic and COPD patients: a quantitative systematic review.

Authors:  Florent Richy; Jean Bousquet; George E Ehrlich; Pierre J Meunier; Elliot Israel; Hirotoshi Morii; Jean-Pierre Devogelaer; Nicola Peel; Muriel Haim; Olivier Bruyere; Jean-Yves Reginster
Journal:  Osteoporos Int       Date:  2003-04-23       Impact factor: 4.507

Review 10.  The osteoporosis of heparinotherapy and systemic mastocytosis.

Authors:  T Bardin; M Lequesne
Journal:  Clin Rheumatol       Date:  1989-06       Impact factor: 2.980

View more
  13 in total

1.  Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder.

Authors:  Christoph U Correll; Johan Detraux; Jan De Lepeleire; Marc De Hert
Journal:  World Psychiatry       Date:  2015-06       Impact factor: 49.548

2.  The association of opioid use with incident lower extremity fractures in spinal cord injury.

Authors:  Laura D Carbone; Amy S Chin; Todd A Lee; Stephen P Burns; Jelena N Svircev; Helen M Hoenig; Titilola Akhigbe; Frances M Weaver
Journal:  J Spinal Cord Med       Date:  2013-03       Impact factor: 1.985

Review 3.  Excess risk of hip fractures attributable to the use of antidepressants in five European countries and the USA.

Authors:  D Prieto-Alhambra; H Petri; J S B Goldenberg; T P Khong; O H Klungel; N J Robinson; F de Vries
Journal:  Osteoporos Int       Date:  2014-01-22       Impact factor: 4.507

Review 4.  Osteoporosis Associated with Epilepsy and the Use of Anti-Epileptics-a Review.

Authors:  Sandra J Petty; Helen Wilding; John D Wark
Journal:  Curr Osteoporos Rep       Date:  2016-04       Impact factor: 5.096

5.  Relationship between use of antidepressants and risk of fractures: a meta-analysis.

Authors:  V Rabenda; D Nicolet; C Beaudart; O Bruyère; J-Y Reginster
Journal:  Osteoporos Int       Date:  2012-05-26       Impact factor: 4.507

6.  Risk factors for fracture in elderly men: a population-based prospective study.

Authors:  M Frost; B Abrahamsen; T Masud; K Brixen
Journal:  Osteoporos Int       Date:  2011-03-16       Impact factor: 4.507

7.  Characteristics of patients who suffer major osteoporotic fractures despite adhering to alendronate treatment: a National Prescription registry study.

Authors:  B Abrahamsen; K H Rubin; P A Eiken; R Eastell
Journal:  Osteoporos Int       Date:  2012-10-16       Impact factor: 4.507

Review 8.  Do Selective Serotonin Reuptake Inhibitors (SSRIs) Cause Fractures?

Authors:  Stuart J Warden; Robyn K Fuchs
Journal:  Curr Osteoporos Rep       Date:  2016-10       Impact factor: 5.096

9.  Pain as the fifth vital sign: exposing the vital need for pain education.

Authors:  Natalia E Morone; Debra K Weiner
Journal:  Clin Ther       Date:  2013-10-18       Impact factor: 3.393

10.  Relationship of opioid use and dosage levels to fractures in older chronic pain patients.

Authors:  Kathleen W Saunders; Kate M Dunn; Joseph O Merrill; Mark Sullivan; Constance Weisner; Jennifer Brennan Braden; Bruce M Psaty; Michael Von Korff
Journal:  J Gen Intern Med       Date:  2010-01-05       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.